Aug 2026
Zonisamide Improves Cognitive Impairment and Psychiatric Symptoms related with SAPAP3 in Mouse Models of Alzheimer's Disease.
ZNS exerts neuroprotective effects in 5xFAD mice and improves AD-related cognitive impairment and AD-like lesions, which establishes ZNS as a promising therapeutic avenue for AD and its associated psychiatric symptoms.
Fangtai Yi, Jianfeng Ma, Rui-Yue Zhao et al.
· European Journal of Pharmaco... · 0 citations